20/20 Biolabs Inc. (AIDX) Financials
AIDX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 6.1 million | 3.0 million |
| March 31, 2026 | 5.8 million | 3.0 million |
| Dec. 31, 2025 | 4.1 million | 4.2 million |
| Sept. 30, 2025 | 3.2 million | 3.1 million |
AIDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -600106 | 371300 |
| March 31, 2026 | -1.3 million | 128440 |
| Dec. 31, 2025 | -511667 | 127230 |
| Sept. 30, 2025 | -385655 | 129649 |
AIDX Net Income
No data available :(
AIDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 4.5 million | 379717 | 572448 |
| March 31, 2026 | 4.2 million | - | 618771 |
| Dec. 31, 2025 | 1.0 billion | 619355 | 664673 |
| Sept. 30, 2025 | 1.1 million | 986457 | 535959 |
AIDX Shares Outstanding
AIDX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 5354 | 257632 | 1.3 million | - |
| March 31, 2026 | 5354 | 153482 | 1.4 million | - |
| Dec. 31, 2025 | - | 130554 | 912709 | - |
| Sept. 30, 2025 | - | 131060 | 814179 | - |
AIDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 730571 | 425844 |
| March 31, 2026 | 353375 | 290491 |
| Dec. 31, 2025 | 538274 | 407857 |
| Sept. 30, 2025 | 417979 | 272913 |
AIDX
Price: $0.38
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.58 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 4.7 million